HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium.

Aim: To evaluate the association between human leukocyte antigen (HLA) alleles and native Escherichia coli asparaginase hypersensitivity (AH) in children with acute lymphoblastic leukemia (ALL) who received Dana-Farber Cancer Institute treatment protocols. Patients & methods: HLA-DQA1, HLA-DRB1 and HLA-DQB1 alleles were retrieved from available whole exome sequencing data of a subset of childhood ALL patients from Quebec ALL cohort and analyzed for an association with AH. PCR assay was developed to analyze associated alleles in the entire discovery and replication cohorts. Results: Two alleles in linkage disequilibrium (HLA-DRB1*07:01 and DQA1*02:01) were associated with AH. Additional analyses, performed to distinguish between HLA-DRB1*07:01 haplotypes with and without DQB1*02:02 allele, showed that the association was dependent on the presence of DQB1*02:02. Conclusion: This study confirms the implication of HLA-DRB1*07:01, DQA1*02:01 and DQB1*02:02 alleles in developing AH in childhood ALL.

[1]  M. Krajinovic,et al.  Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study , 2019, PloS one.

[2]  Ramneek Gupta,et al.  Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL2008 , 2018, British journal of haematology.

[3]  M. Relling,et al.  Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII , 2018, Haematologica.

[4]  A. Falus,et al.  HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia , 2017, Haematologica.

[5]  D. Neuberg,et al.  Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients , 2017, Oncotarget.

[6]  S. Ahuja,et al.  L-asparaginase in the treatment of patients with acute lymphoblastic leukemia , 2016, Journal of pharmacology & pharmacotherapeutics.

[7]  A. Baruchel,et al.  Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation , 2016, Haematologica.

[8]  M. Krajinovic,et al.  Current perspective on pediatric pharmacogenomics , 2016, Expert opinion on drug metabolism & toxicology.

[9]  Z. Jakab,et al.  Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity , 2015, PloS one.

[10]  D. Sinnett,et al.  Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes , 2015, BMC Cancer.

[11]  M. Loh,et al.  Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. , 2015, Blood.

[12]  M. Relling,et al.  Effect of Premedications in a Murine Model of Asparaginase Hypersensitivity , 2015, Journal of Pharmacology and Experimental Therapeutics.

[13]  B. Asselin,et al.  Asparaginase pharmacokinetics and implications of therapeutic drug monitoring , 2015, Leukemia & lymphoma.

[14]  M. Tremelling,et al.  HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants , 2014, Nature Genetics.

[15]  M. Loh,et al.  HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. , 2014, Blood.

[16]  D. Neuberg,et al.  Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia , 2014, Clinical Cancer Research.

[17]  Chuong B. Do,et al.  A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci , 2013, Nature Genetics.

[18]  Kari Stefansson,et al.  Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization , 2013, Nature Genetics.

[19]  M. Relling,et al.  Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[21]  D. Neuberg,et al.  ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia. , 2011, Blood.

[22]  K. King,et al.  HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Relling,et al.  Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity , 2010, Clinical pharmacology and therapeutics.

[24]  H. Çaksen,et al.  A Desensitization Protocol in Children With L-Asparaginase Hypersensitivity , 2010, Journal of pediatric hematology/oncology.

[25]  E. Bleecker,et al.  Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. , 2010, The Journal of allergy and clinical immunology.

[26]  D. Neuberg,et al.  Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000) , 2009, Leukemia.

[27]  M. Relling,et al.  Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  F. Finkelman.  Anaphylaxis: lessons from mouse models. , 2007, The Journal of allergy and clinical immunology.

[29]  M. Loh,et al.  Genome-wide Analysis Links Nfatc2 with Asparaginase Hypersensitivity Key Points , 2022 .

[30]  D. Neuberg,et al.  ATF 5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia Running title : Polymorphisms of aspraginase pathway and ALL outcome , 2011 .

[31]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..